Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anh T Vo

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
BMC Microbiology|September 16, 2021
Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequencesAlexander Eng, Hillary S Hayden, Christopher E Pope, et al.
Nature Medicine|January 22, 2020
Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failureHillary S Hayden, Alexander Eng, Christopher E Pope, et al.
The Journal of Clinical Investigation|March 28, 2023
Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persistDavid P Nichols, Sarah J Morgan, Michelle Skalland, et al.
Mbio|December 14, 2021
Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis InfectionsSamantha L Durfey, Sudhakar Pipavath, Anna Li, et al.
Cell Reports|February 21, 2019
Human and Extracellular DNA Depletion for Metagenomic Analysis of Complex Clinical Infection Samples Yields Optimized Viable Microbiome ProfilesMaria T Nelson, Christopher E Pope, Robyn L Marsh, et al.
Plos Pathogens|January 22, 2020
CFTR dysregulation drives active selection of the gut microbiomeStacey M Meeker, Kevin S Mears, Naseer Sangwan, et al.
Thorax|July 8, 2020
Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiomeMaria T Nelson, Daniel J Wolter, Alexander Eng, et al.
Cell Host & Microbe|August 6, 2025
Pseudomonas infections persisting after CFTR modulators are widespread throughout the lungs and drive lung inflammationSamantha L Durfey, Siddhartha G Kapnadak, Tahuanty Pena, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
BMC Microbiology|September 16, 2021
Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequencesAlexander Eng, Hillary S Hayden, Christopher E Pope, et al.
Nature Medicine|January 22, 2020
Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failureHillary S Hayden, Alexander Eng, Christopher E Pope, et al.
The Journal of Clinical Investigation|March 28, 2023
Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persistDavid P Nichols, Sarah J Morgan, Michelle Skalland, et al.
Mbio|December 14, 2021
Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis InfectionsSamantha L Durfey, Sudhakar Pipavath, Anna Li, et al.
Cell Reports|February 21, 2019
Human and Extracellular DNA Depletion for Metagenomic Analysis of Complex Clinical Infection Samples Yields Optimized Viable Microbiome ProfilesMaria T Nelson, Christopher E Pope, Robyn L Marsh, et al.
Plos Pathogens|January 22, 2020
CFTR dysregulation drives active selection of the gut microbiomeStacey M Meeker, Kevin S Mears, Naseer Sangwan, et al.
Thorax|July 8, 2020
Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiomeMaria T Nelson, Daniel J Wolter, Alexander Eng, et al.
Cell Host & Microbe|August 6, 2025
Pseudomonas infections persisting after CFTR modulators are widespread throughout the lungs and drive lung inflammationSamantha L Durfey, Siddhartha G Kapnadak, Tahuanty Pena, et al.
Pageof 2